Acurx Pharmaceuticals, Inc. (ACXP)
2.38
-0.11
(-4.42%)
USD |
NASDAQ |
Apr 17, 16:00
2.40
+0.02
(+0.84%)
After-Hours: 20:00
Acurx Pharmaceuticals Research and Development Expense (Quarterly) : 0.2818M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Apyx Medical Corp. | 0.944M |
| Quince Therapeutics, Inc. | 12.60M |
| Lantern Pharma, Inc. | 2.745M |
| Sensei Biotherapeutics, Inc. | 2.536M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |